Tenet Healthcare (NYSE:THC) sees FY12 EBITDA of $1.2B-1.3B, in-line with consensus, and says...

Tenet Healthcare (NYSE:THC) sees FY12 EBITDA of $1.2B-1.3B, in-line with consensus, and says achieving FY11 EBITDA of $1.175B-1.275B depends on whether "certain significant favorable pending reimbursement settlements" are recorded in Q4. (PR)